Sayagcot, Normia M.

HRN: 05-85-46  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2022
CEFUROXIME 500MG (TAB)
06/11/2022
06/18/2022
ORAL
500mg
BID
UTI
Waiting Final Action 
06/12/2022
CEFTRIAXONE 1G (VIAL)
06/12/2022
06/19/2022
IV
2g
Q24
UTI
Waiting Final Action 
11/25/2022
MUPIROCIN 2%, 15G (TUBE)
11/25/2022
12/02/2022
TOPICAL
2%
BID
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: